Next Article in Journal
Imaging Study of Pseudotumoral Chronic Sialadenitis with Cystic-Like Pattern in a Sjögren Syndrome Patient
Previous Article in Journal
Welcome to the New Open Access Reports
Article Menu

Export Article

Open AccessCase Report

Cognitive Evolution of a Patient Who Suffered a Subarachnoid Haemorrhage Eight Years Ago, after Being Treated with Growth Hormone, Melatonin and Neurorehabilitation

1
Neuropsychology, Medical Center Foltra, 15886 Teo, Spain
2
Occupational Therapy, Medical Center Foltra, 15886 Teo, Spain
3
Auditory Stimulation and Neurosensory Integration (EINA), Medical Center Foltra, 15886 Teo, Spain
4
Scientific Direction, Medical Center Foltra, 15886 Teo, Spain
*
Author to whom correspondence should be addressed.
Received: 25 January 2018 / Revised: 8 February 2018 / Accepted: 10 February 2018 / Published: 12 February 2018
Full-Text   |   PDF [3873 KB, uploaded 12 February 2018]   |  

Abstract

To describe the cognitive evolution of a patient who suffered a subarachnoid haemorrhage resulting in a total loss of his cognitive functions. The patient was initially treated with GH (0.8 mg/day), melatonin (50 mg/day) and neurorehabilitation 1 year after his brain damage, during 3 months. Then continued with GH (0.5 mg/day, 6 months/year, during 2 years) and melatonin treatments and neurorehabilitation (3 days/week). 5 years later the patient came back to our Centre due to the absence of recent memory and personal and spatio-temporal orientation and he received an intensive specific neurorehabilitation, including EINA (Auditory Stimulation and Neurosensory Integration), together with GH (0.8 mg/day) and melatonin, for 6 months. At discharge of his first treatment period cognitive functions showed very poor changes but these had been improved when he came back 5 years later. A review carried out 8 years after SHA demonstrated that the patient significantly recovered in all the cognitive functions and he was able to live an independent life. GH plays a key role on cognition, including its actions on recent memory. Melatonin, in turn, helps as a neuroprotective agent. A specific neurostimulation must be performed so that the effects of GH can be expressed. Within neurostimulation, EINA seems to play a very important role for enhancing the effects of medical and rehabilitative treatments on brain plasticity. View Full-Text
Keywords: subarachnoid haemorrhage; anterior communicating artery aneurysm; cognitive functions; growth hormone; melatonin; neurorehabilitation; auditory stimulation and neurosensory integration; occupational therapy subarachnoid haemorrhage; anterior communicating artery aneurysm; cognitive functions; growth hormone; melatonin; neurorehabilitation; auditory stimulation and neurosensory integration; occupational therapy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Quintana, A.; Agra, C.; Outeiral, L.; Devesa, A.; Llorente, D.; Devesa, J. Cognitive Evolution of a Patient Who Suffered a Subarachnoid Haemorrhage Eight Years Ago, after Being Treated with Growth Hormone, Melatonin and Neurorehabilitation. Reports 2018, 1, 2.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Reports EISSN 2571-841X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top